Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Seroincidence of non-typhoid Salmonella infections: convenience vs. random community-based sampling

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Male fertility before and after androgen abuse

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: a study of 125 727 individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
SUMMARY The antibiotic trimethoprim acts as a folate antagonist. Since trophoblasts are very sensitive to drugs that interfere with the folic acid cycle and thereby inhibit DNA synthesis, use of trimethoprim during the first trimester could be associated with miscarriage. A nationwide cohort study including all women in Denmark with a registered pregnancy between 1997 and 2005 was conducted. We used nationwide registers to identify all women giving birth, having a record of miscarriage or induced abortion. Data on exposure to trimethoprim were obtained from the National Prescription Register. Cox proportional hazard regression analysis with exposure to trimethoprim as a time-dependent variable was used to estimate the risk of miscarriage. The adjusted hazard ratio of having a miscarriage after exposure to trimethoprim in the first trimester compared to non-exposure was 2·04 (95% confidence interval 1·43-2·91). Our results indicate that trimethoprim exposure in the first trimester is associated with a doubling of the hazard of miscarriage.
Original languageEnglish
JournalEpidemiology and Infection
Pages (from-to)1-7
Number of pages7
ISSN0950-2688
DOIs
Publication statusPublished - 2012

ID: 36469874